Form 8-K - Current report:
SEC Accession No. 0001472375-24-000106
Filing Date
2024-12-10
Accepted
2024-12-10 17:12:45
Documents
13
Period of Report
2024-12-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ixform8k.htm   iXBRL 8-K 20466
  Complete submission text file 0001472375-24-000106.txt   187451

Data Files

Seq Description Document Type Size
2 SCHEMA DOCUMENT rgpx-20241210.xsd EX-101.SCH 2702
3 LABELS LINKBASE DOCUMENT rgpx-20241210_lab.xml EX-101.LAB 34011
4 PRESENTATION LINKBASE DOCUMENT rgpx-20241210_pre.xml EX-101.PRE 22150
15 EXTRACTED XBRL INSTANCE DOCUMENT ixform8k_htm.xml XML 3353
Mailing Address 5348 VEGAS DRIVE, SUITE 177 LAS VEGAS NV 89108
Business Address 5348 VEGAS DRIVE, SUITE 177 LAS VEGAS NV 89108 305-927-5191
REGENEREX PHARMA, INC. (Filer) CIK: 0001357878 (see all company filings)

EIN.: 980479983 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-53230 | Film No.: 241539352
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)